Association Between Oseltamivir Timing and Clinical Outcomes in Hospitalized Children with Influenza: A Retrospective Cohort Study. [PDF]
Albohassan HS +5 more
europepmc +1 more source
Safety and efficacy of major antiviral and immune therapies in pregnancy for maternal viral infections: evidence synthesis of maternal and neonatal outcomes. [PDF]
Sleman S +4 more
europepmc +1 more source
Prognostic factors in H7N9 avian influenza: a systematic review based on case reports. [PDF]
Li F, Song K, Ren X.
europepmc +1 more source
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice. [PDF]
Andreev K +5 more
europepmc +1 more source
Increased levels of α2-3- and α2-6-linked sialic acids during airway inflammation govern influenza A binding to peripheral airway mucins in a subtype-dependent manner. [PDF]
Benktander J +6 more
europepmc +1 more source
Structural and temporal dynamics of pediatric influenza prevention and treatment: a comprehensive bibliometric analysis of historical evolution and emerging trends. [PDF]
Hong J +5 more
europepmc +1 more source
Effectiveness of oseltamivir in hospitalised obstetric patients with COVID-19: a retrospective cohort study using a Brazilian national database. [PDF]
Burvill A +3 more
europepmc +1 more source
A cost-effectiveness analysis of baloxavir marboxil versus oseltamivir for seasonal influenza treatment in China. [PDF]
Zheng F, Tang Y, Jiang H.
europepmc +1 more source
A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance. [PDF]
Zhang L +11 more
europepmc +1 more source
Antiviral activities of multiple antivirals against highly pathogenic avian influenza A H5N1 <i>in vitro</i> and in mice. [PDF]
Liu D +8 more
europepmc +1 more source

